The Nutrient Guide: Vitamins, Minerals, Fats, and Amino Acids, What Running Low Looks Like, and How to Test For It
2026-11-10Same post, two depths. Switch any time; the research version has the enzyme names, lab markers, and doses. Written from a research and education perspective: a model of what may be going on and what the published literature suggests would address it if the model is right, not medical advice or a treatment plan.
This is the reference page I wish someone had handed me years ago. For each nutrient your body cannot make enough of on its own, it covers: what the nutrient does, what running a little low looks like (the part doctors are not trained to notice), what a real deficiency looks like, what a severe one looks like, which test actually measures it (and why the usual one often does not), what form to take if food is not enough, and the things to know that trip people up.
Two ideas run through the whole page. First, there is a big gap between "not deficient" and "enough." The standard lab range tells you whether you are at risk of the classic deficiency disease. It does not tell you whether your enzymes have what they need to run at full speed. I call that gap subclinical deficiency, and it is where most of the fatigue, pain, and brain fog on this site lives. Second, a blood level is not the same as what is inside your cells. Several nutrients look fine in the blood while the cells are starving, and the page flags each one.
I am a scientist, not a physician, and this is education, not medical advice. Get the tests through your own provider and make decisions with them.
How to read the ranges
For each nutrient I give the standard range (what the lab prints) and a functional range (where the research suggests enzymes actually run well). The functional ranges are narrower and are drawn from studies of enzyme activity, symptom thresholds, and outcomes, not from the average of whoever happened to get tested. They are a research position, not a diagnosis, and your provider may reasonably disagree.
Part 1: The B vitamins (the cofactors for energy and repair)
B1, thiamine
What it does: Burns sugar for energy. The enzyme that moves sugar into the mitochondria cannot work without it, and neither can the one that lets your cells make the building blocks for DNA.
Running low: Fatigue that gets worse with carbs, brain fog, anxiety, a racing heart on standing, poor exercise tolerance, bloating and slow digestion, cold hands and feet.
Deficient: Beriberi: nerve pain and weakness in the legs, a fast heart, swelling, or (dry form) neuropathy. Wernicke's: confusion, eye movement problems, unsteady walking. These show up fast in heavy drinkers, after bariatric surgery, and in anyone vomiting for weeks.
Severe: Heart failure, permanent memory damage (Korsakoff's), coma.
Testing: Serum thiamine is nearly useless; it reflects what you ate yesterday. The useful tests are whole-blood thiamine diphosphate (the active form, measured in red cells) or erythrocyte transketolase activity with a "TPP effect" (you add thiamine to the sample and see how much the enzyme speeds up; a big jump means you were short). Functional target: whole-blood TPP in the upper half of the range, TPP effect under 15 percent.
Best form: Benfotiamine (fat-soluble, 150 to 300 mg) for nerves and blood sugar; thiamine HCl in high doses (300 to 600 mg or more) when fatigue is the main picture; TTFD (a form that crosses into cells and the brain without a transporter) when the usual forms do nothing.
Things to know: Thiamine needs magnesium to be activated. Sugar, alcohol, coffee and tea with meals, and raw fish all lower it. The gut bacteria in overgrowth eat it. And here is the one almost nobody knows: the transporter that moves folate into your cells trades it for thiamine's active form, so a person who is short on thiamine can have high folate in the blood that cannot get into the cells. More on that under folate.
B2, riboflavin
What it does: Makes FAD, the cofactor for the enzymes that burn fat, run the methylation cycle (MTHFR runs on it), recycle glutathione, and break down histamine (MAO) and dopamine.
Running low: Cracks at the corners of the mouth, a sore or magenta tongue, light sensitivity, migraines, fatigue, histamine reactions that do not make sense, and a methylfolate or methyl-B12 reaction (because MTHFR without B2 cannot keep up).
Deficient: Ariboflavinosis: the mouth and tongue signs plus seborrheic dermatitis around the nose, anemia, and nerve symptoms.
Severe: Rare on its own; usually part of a wider B-vitamin deficiency.
Testing: Erythrocyte glutathione reductase activity coefficient (EGRAC): same trick as thiamine, add the cofactor and see how much the enzyme wakes up. Under 1.2 is replete; over 1.4 is deficient. Plasma riboflavin is a poor substitute.
Best form: Riboflavin-5-phosphate (the active form), 25 to 100 mg, or plain riboflavin 100 to 400 mg for migraine (that is the dose with trials).
Things to know: Bright yellow urine means you absorbed it, not that you have too much. Riboflavin is the single cheapest fix for a slow MTHFR variant and it is the one that rescues the enzyme in the lab. Thyroid hormone is needed to turn riboflavin into FAD, so low thyroid lowers B2 function.
B3, niacin
What it does: Makes NAD, which every energy reaction and every DNA repair enzyme uses.
Running low: Fatigue, low mood, poor stress tolerance, skin that is irritable in sun, digestive upset.
Deficient: Pellagra: dermatitis on sun-exposed skin, diarrhea, and dementia (the three Ds). Rare in the developed world except in alcoholism, carcinoid syndrome, and a few genetic conditions.
Severe: Death, historically.
Testing: Urinary N-methylnicotinamide is the research test; there is no good routine blood test. Most of the time the picture is read from symptoms and from the tryptophan-to-NAD pathway on an organic acids test.
Best form: Niacinamide 250 to 500 mg for NAD without the flush; nicotinamide riboside if you want to pay more for a transporter-independent route; nicotinic acid (the flushing form) only when a lipid effect is wanted. Tryptophan in the diet makes niacin too, if B6 and iron are adequate.
Things to know: High-dose niacinamide can suppress the sirtuin enzymes you were trying to support, so more is not better. Niacin competes with other methylated compounds for methyl groups when cleared (it is methylated to be excreted), so a big niacin dose can drain methylation, which is also why niacin is used to stop a methyl-donor overdose.
B5, pantothenic acid
What it does: Makes coenzyme A, which carries every fat and most of metabolism around the cell. Also needed to make cortisol and other steroid hormones.
Running low: Burning feet, fatigue, poor stress tolerance, acne.
Deficient and severe: Very rare; "burning feet syndrome" in famine.
Testing: No good routine test. It is in nearly every food.
Best form: Pantethine 300 to 600 mg if you want a lipid effect; plain B5 otherwise, and it is in any B complex.
Things to know: Rarely the problem on its own.
B6, pyridoxine (active form: P5P)
What it does: The cofactor for over 140 enzymes: making serotonin, dopamine, GABA, and histamine (and breaking histamine down in the gut), moving amino acids around, the first step of making heme, and the transsulfuration step that makes glutathione from homocysteine.
Running low: Anxiety, poor dream recall or vivid nightmares, irritability, PMS, carpal tunnel, a sore tongue, histamine symptoms, elevated homocysteine that does not respond to folate and B12.
Deficient: Microcytic anemia (it is needed for heme), seborrheic dermatitis, cracked lips, confusion, depression, weakened immunity, seizures in infants.
Severe: Seizures, peripheral neuropathy.
Testing: Plasma pyridoxal-5-phosphate (P5P) is the right test; the standard range is wide (about 20 to 125 nmol/L) and the functional target is above 50. A high plasma P5P with symptoms of deficiency means the vitamin is not getting into cells (low alkaline phosphatase, low zinc, or inflammation does this).
Best form: P5P, 25 to 50 mg. Avoid long-term pyridoxine (the cheap form) above 50 mg: at high doses it blocks its own active form and causes the very neuropathy you were trying to prevent.
Things to know: The B6-neuropathy paradox above is real and shows up in people taking 100 mg plus for years. Zinc and magnesium are needed to activate B6. Oral contraceptives, hydralazine, isoniazid, and alcohol all lower it. If your plasma B6 is high but you look deficient, check zinc and alkaline phosphatase.
B7, biotin
What it does: The cofactor for the carboxylase enzymes that make fat, break down certain amino acids, and refill the Krebs cycle.
Running low: Hair thinning, brittle nails, scaly rash around the eyes and mouth, fatigue, tingling.
Deficient: The rash and hair loss plus depression, lethargy, numbness; seen in biotinidase deficiency, long-term raw egg white eating, and some anti-seizure drugs.
Testing: Urinary 3-hydroxyisovaleric acid (rises when biotin is low); plasma biotin is unreliable.
Best form: Biotin 1 to 5 mg if needed. Tell your provider; biotin supplements interfere with many lab tests (thyroid, troponin) and can produce falsely normal or abnormal results.
B9, folate
What it does: Carries single carbons for building DNA, for the methylation cycle, and for recycling BH4 (which makes serotonin, dopamine, and nitric oxide).
Running low: Fatigue, low mood, poor concentration, elevated homocysteine, a tongue that is sore or smooth, canker sores, mild anemia with large red cells.
Deficient: Megaloblastic anemia, glossitis, diarrhea, neural tube defects in pregnancy.
Severe: Pancytopenia, severe anemia.
Testing: This is where it gets interesting. Serum folate reflects recent intake and can be high in someone whose cells are empty. Red blood cell (RBC) folate reflects the last three months of what actually got into cells, and it is the better test. Functional target: RBC folate above about 1,000 nmol/L (over 440 ng/mL). Homocysteine is the functional readout: above 9 means the methylation cycle is short of folate, B12, B2, B6, or betaine.
Best form: Folinic acid (5-formyl-THF) is the safest default for most people, because it joins the folate cycle one step before MTHFR and lets your enzyme set the pace. Methylfolate (5-MTHF) is the fastest-acting but can cause anxiety, insomnia, and a racing heart in people whose downstream steps are slow (the methyl trapping post is here). Avoid folic acid: the synthetic form has to be converted by a slow enzyme, and the unconverted leftover competes with real folate for the way into cells.
Things to know: High serum folate with a low RBC folate is a pattern worth stopping on. It means folate is in the blood and not in the cells. Three reasons: you are taking folic acid and it is not converting; the cells are not pulling it in; or, and this is the one I think is under-appreciated, you are short on thiamine. The transporter that carries folate into most cells (the reduced folate carrier) works as an exchanger, and the thing it trades out is thiamine's active form, TPP. If there is not enough TPP inside the cell to trade, folate stays outside. In practice this means a stubborn high-serum, low-RBC folate pattern is a reason to look at thiamine before you raise the folate dose.
Also: folate and B12 have to be treated together. Giving folate to someone who is B12 deficient fixes the anemia and lets the nerve damage continue silently. Check B12 (properly, see next) before you load folate.
B12, cobalamin
What it does: Two enzymes only, but they are big ones: methionine synthase (the methylation cycle and recycling folate) and methylmalonyl-CoA mutase (burning odd-chain fats and some amino acids in the mitochondria). Nerve insulation depends on both.
Running low: Fatigue, numbness or tingling in the feet, brain fog, low mood, balance that is a little off, elevated homocysteine, elevated methylmalonic acid.
Deficient: Megaloblastic anemia, neuropathy, memory loss, depression, glossitis. The nerve damage can come years before the anemia and is permanent if it goes on long enough.
Severe: Subacute combined degeneration of the spinal cord (loss of position sense, weakness, spasticity), dementia, psychosis.
Testing: Serum B12 is a bad test. The standard range starts around 200 pg/mL, and nerve damage is well documented at 200 to 400. Worse, serum B12 can be high while cells are empty (liver disease, some supplements, and a gene variant that makes a B12 binding protein that cells cannot use). The tests that reflect what cells actually have: methylmalonic acid (MMA, above about 270 nmol/L means the mitochondrial enzyme is starving) and homocysteine. Holotranscobalamin (the "active B12," the fraction bound to the protein cells can take up) is the best single serum test if your lab offers it. Functional targets: serum B12 above 500, MMA under 270, holoTC above 50.
Best form: Hydroxocobalamin plus adenosylcobalamin under the tongue, 1,000 to 2,000 mcg. Hydroxocobalamin is the storage form; cells convert it to whichever active form they need. Adenosylcobalamin is the mitochondrial form. Neither carries a methyl group, so neither will wire you up. Methylcobalamin is fine for people who tolerate methyl donors. Cyanocobalamin (the cheap form) has to be stripped of its cyanide group first and is the weakest choice. Injections (hydroxocobalamin, 1 mg weekly for eight weeks) when MMA is high or there is nerve involvement.
Things to know: Metformin, PPIs and H2 blockers, nitrous oxide (including dental and recreational), vegetarian and vegan diets, and gut inflammation all lower B12. Oxidative stress knocks B12 off its enzyme, so an inflamed person can be functionally B12 deficient with a normal level. B12 taken at night can disrupt sleep in some people; morning is better.
Choline (an honorary B vitamin)
What it does: Builds phosphatidylcholine for every membrane in the body, is the raw material for acetylcholine (memory, muscle, the parasympathetic nerves), and donates methyl groups through betaine.
Running low: Fatty liver, brain fog, muscle aches with a raised CK, elevated homocysteine, poor memory.
Deficient: Fatty liver and muscle damage, demonstrated in controlled feeding studies within weeks. Most people do not meet the adequate intake.
Testing: No good routine blood test. Plasma choline is unreliable. Read it from intake (eggs and liver are the only dense sources), from liver fat, and from homocysteine.
Best form: Eggs (about 150 mg each) and liver first. Phosphatidylcholine (sunflower lecithin) 1,200 to 2,400 mg or citicoline 250 to 500 mg if intake falls short. Alpha-GPC if the goal is acetylcholine.
Things to know: If you are not eating eggs, you are almost certainly short. Estrogen drives the gene that makes choline in-house, so post-menopausal women and men need more from food. Choline spares your methylation budget: supply it and the body stops spending methyl groups to make it.
Part 2: The fat-soluble vitamins
Vitamin A
What it does: Vision, the gut and lung lining, immune regulation, thyroid hormone receptor function, and gene expression everywhere.
Running low: Poor night vision, dry eyes, frequent respiratory infections, rough bumpy skin on the backs of the arms, poor wound healing.
Deficient: Night blindness, Bitot's spots on the eyes, severe infections.
Severe: Corneal damage and blindness.
Testing: Serum retinol, with the caveat that it is held constant by the liver until stores are nearly gone, and it drops in inflammation. Retinol-binding protein helps. Functional target: retinol in the upper half of the range with a normal CRP.
Best form: Liver and cod liver oil (preformed retinol). Beta-carotene from plants converts to vitamin A poorly in a large share of people (the BCO1 variants), so "eat carrots" is not enough for them. Retinyl palmitate 3,000 to 5,000 IU if supplementing; do not go high in pregnancy.
Things to know: Zinc is needed to move vitamin A out of the liver, so a zinc-deficient person can have a full liver and empty blood. Vitamin A and D work as a pair at the receptor; high-dose D without A causes problems and vice versa.
Vitamin D
What it does: Calcium and bone, obviously; also immune regulation, mast cell calming, muscle strength, insulin sensitivity, and the expression of hundreds of genes.
Running low: Fatigue, muscle aches, low mood in winter, frequent infections, worse allergies and histamine symptoms.
Deficient: Bone and muscle pain, proximal weakness, osteomalacia in adults, rickets in children.
Severe: Rickets, fractures, hypocalcemic seizures in infants.
Testing: 25-hydroxyvitamin D is the right test. The standard "sufficient" cutoff is 30 ng/mL; the functional target from the outcome literature is 50 to 70. Do not test 1,25-D as a status marker; it is a hormone that goes up in deficiency and in inflammation.
Best form: D3 with K2 (MK-7), 2,000 to 5,000 IU daily to reach target, with a fat-containing meal, and recheck in three months. Carlson D3 4,000 IU with K2 and Thorne D/K2 liquid are the ones I like.
Things to know: Magnesium is needed to activate D; supplementing D into a magnesium deficiency can make symptoms worse. Dark skin, obesity, and age all raise the dose needed. Some people have a variant in the vitamin D binding protein that makes their measured level read low while function is fine; a normal PTH and calcium suggest that.
Vitamin E
What it does: The main antioxidant inside cell membranes, and a signaling molecule in its own right.
Running low: Hard to see; mild neuropathy, muscle weakness, poor exercise recovery, worse lipid oxidation.
Deficient: Neuropathy with loss of position sense, unsteady gait, retinal damage, hemolysis. Mostly in fat malabsorption and a few genetic conditions.
Testing: Serum alpha-tocopherol, ideally corrected for total lipids (a high-cholesterol person carries more E for the same tissue level).
Best form: Mixed tocotrienols plus mixed tocopherols (Procapsin is my pick), 100 to 200 mg. Avoid high-dose synthetic alpha-tocopherol alone; it displaces gamma-tocopherol and the tocotrienols, which do different jobs.
Things to know: Vitamin C regenerates spent vitamin E, and glutathione regenerates vitamin C; the antioxidant network only works as a network.
Vitamin K
What it does: K1 activates clotting factors; K2 (MK-4 and MK-7) activates the proteins that put calcium in bone and keep it out of arteries, and is needed for several hormone and nerve functions.
Running low: Easy bruising, heavy periods, poor bone density, arterial calcification on imaging.
Deficient: Bleeding.
Testing: INR only catches severe K1 deficiency. Undercarboxylated osteocalcin or dp-ucMGP are the functional K2 tests, available at specialty labs.
Best form: K2 as MK-7, 100 to 200 mcg, with vitamin D. Natto, hard cheeses, egg yolks, and liver are the food sources.
Things to know: Warfarin blocks K recycling; anyone on it needs a steady, not zero, intake and prescriber oversight before changing anything. Antibiotics lower gut production. Fat is needed for absorption.
Part 3: Vitamin C and the minerals
Vitamin C
What it does: Collagen (the enzyme that stabilizes it needs vitamin C), making carnitine and norepinephrine, iron absorption, regenerating vitamin E and BH4, and calming mast cells.
Running low: Easy bruising, bleeding gums, slow wound healing, fatigue, more frequent colds, achy joints, hair that corkscrews.
Deficient: Scurvy: perifollicular bleeding, gum disease, old wounds reopening, anemia, depression. Seen in people who eat no fresh produce, in alcoholism, and after bariatric surgery.
Severe: Hemorrhage, death.
Testing: Plasma ascorbate (fasting, handled carefully); leukocyte ascorbate reflects tissue stores better but is rarely available. Functional target: plasma above 50 micromol/L.
Best form: Liposomal vitamin C (Dr. Mercola's) 1,000 mg, or plain ascorbic acid 500 mg two or three times a day; the body absorbs small doses better than one large one.
Things to know: Smokers, people under oxidative stress, and anyone bendy need more. Vitamin C raises iron absorption, which is good if ferritin is low and a problem if you have hemochromatosis. Very high doses can raise oxalate in susceptible people.
Magnesium
What it does: Required by every enzyme that uses ATP (which is most of them), by the enzymes that activate thiamine and vitamin D, by the methylation cycle, and as the natural blocker of the NMDA receptor (which is why it calms nerves and mast cells).
Running low: Muscle cramps and twitches, eye twitches, insomnia, anxiety, constipation, headaches, palpitations, sugar cravings, PMS, poor stress tolerance. This is the most common subclinical deficiency I see.
Deficient: Tetany, arrhythmia, low potassium and calcium that will not correct until magnesium is replaced, seizures.
Severe: Fatal arrhythmia.
Testing: Serum magnesium is almost worthless; the body holds it in a tight range by pulling from bone and muscle, so it only drops when you are badly depleted. RBC magnesium is better (functional target: upper half of the range, above about 5.5 mg/dL in most labs). A magnesium loading test is the gold standard and nobody does it.
Best form: Glycinate or bisglycinate at night for sleep and nerves; malate during the day for energy (Seeking Health Magnesium Malate powder); citrate if constipated; threonate if the goal is the brain. 300 to 400 mg elemental, more to bowel tolerance. Oxide is poorly absorbed.
Things to know: PPIs, diuretics, alcohol, high sugar, stress, and sweating all lose it. Calcium supplements without magnesium make things worse. Low magnesium makes vitamin D supplementation less effective and can make it cause symptoms.
Zinc
What it does: Hundreds of enzymes, immune function, taste and smell, wound healing, insulin storage, moving vitamin A out of the liver, making stomach acid, activating B6.
Running low: Frequent colds, slow wound healing, white spots on nails, poor taste or smell, acne, low appetite, hair thinning, low stomach acid.
Deficient: Dermatitis around the mouth and groin, diarrhea, hair loss, severe infections, growth failure in children, hypogonadism.
Testing: Plasma or serum zinc, fasting, with the caveat that it drops in inflammation and after meals. Functional target: upper half of the range. Alkaline phosphatase (a zinc enzyme) on the low side is a clue. Check copper at the same time, always.
Best form: Zinc picolinate or bisglycinate 15 to 30 mg, balanced with copper (Jarrow Zinc Balance has both). Never take zinc alone long term.
Things to know: Zinc blocks copper absorption by inducing a protein that traps copper in the gut wall. Months of zinc alone produces a copper deficiency that looks like B12 deficiency (anemia and neuropathy). This is probably the most common supplement-induced deficiency I see. Phytates in grains and legumes block zinc; PPIs lower it.
Copper
What it does: The enzyme that cross-links collagen, the enzyme that makes norepinephrine from dopamine, complex IV of the electron transport chain, superoxide dismutase, iron transport (ceruloplasmin), and breaking down histamine in the gut (DAO is a copper enzyme).
Running low: Fatigue, low blood pressure on standing (not enough norepinephrine), histamine reactions, easy bruising, graying hair early, poor wound healing, anemia that does not respond to iron.
Deficient: Anemia and low white cells, neuropathy and unsteady gait indistinguishable from B12 deficiency, bone loss. Causes: zinc supplements, bariatric surgery, high-dose vitamin C over years, denture cream with zinc.
Testing: Serum copper and ceruloplasmin together. Both rise in inflammation and on estrogen, so a "normal" copper in an inflamed person may be hiding a deficiency. Functional target: copper and ceruloplasmin both in the middle of the range, with a copper-to-zinc ratio near 1.
Best form: Liver and oysters first. Copper bisglycinate 1 to 2 mg only when tested low, and only after accounting for the copper in liver.
Things to know: Copper in excess is harmful and the Wilson's disease variants are not rare, so this is a test-then-supplement mineral. The ratio with zinc matters more than either alone.
Iron
What it does: Hemoglobin, obviously; also the enzymes that make dopamine and serotonin, the collagen hydroxylases, the carnitine synthesis enzymes, thyroid peroxidase, and the iron-sulfur clusters in the electron transport chain.
Running low: Fatigue, restless legs, hair shedding, cold intolerance, a racing heart on standing, poor exercise tolerance, brain fog, ice cravings, brittle nails. All of this happens with a normal hemoglobin.
Deficient: Iron deficiency anemia: pallor, breathlessness, spoon nails, sore tongue.
Severe: Heart failure from anemia.
Testing: Ferritin is the storage marker, and the standard lower limit (often 15 to 30 ng/mL) is far too low for symptoms. Functional target: ferritin 50 to 100, higher (over 75) if restless legs. Ferritin rises in inflammation, so pair it with CRP and transferrin saturation (functional target 25 to 40 percent). Hemoglobin is the last thing to drop.
Best form: Red meat and liver (heme iron, absorbed several times better than plant iron). Iron bisglycinate 25 to 50 mg every other day with vitamin C, not daily (daily dosing raises hepcidin, which blocks the next day's absorption). Recheck at 12 weeks. IV iron through a provider when oral fails or ferritin is very low with symptoms.
Things to know: Never supplement iron without a ferritin and transferrin saturation; hemochromatosis variants are common and iron overload is as damaging as deficiency. Low stomach acid, PPIs, coffee and tea with meals, calcium, and gut inflammation all block absorption. Copper is needed to move iron around, so iron-refractory anemia is a copper question. Low iron alone can cause a POTS picture.
Selenium
What it does: The glutathione peroxidases and thioredoxin reductases (antioxidant defense), the deiodinases (converting T4 to the active T3), and sperm formation.
Running low: Low free T3 with a normal TSH, fatigue, thyroid antibodies, poor antioxidant capacity, muscle weakness.
Deficient: Keshan cardiomyopathy and Kashin-Beck joint disease (in low-selenium soil regions), hypothyroidism.
Testing: Serum or plasma selenium (functional target around 120 to 150 mcg/L) or glutathione peroxidase activity.
Best form: Two Brazil nuts a day (though content varies wildly by soil), or selenomethionine 100 to 200 mcg.
Things to know: The window is narrow; above 400 mcg a day is toxic (hair loss, nail changes, nerve symptoms). Selenium modestly lowers thyroid antibodies in several trials. Iodine without selenium can worsen autoimmune thyroid disease.
Iodine
What it does: Thyroid hormone, and breast and ovarian tissue health.
Running low: Fatigue, cold intolerance, weight gain, fibrocystic breasts, goiter, poor concentration.
Deficient: Goiter, hypothyroidism, developmental delay in children of deficient mothers.
Testing: Urinary iodine (spot or 24-hour), with the caveat that it reflects recent intake. Functional target: urinary iodine 100 to 200 mcg/L.
Best form: Seaweed, fish, eggs, dairy, iodized salt. Supplement only at modest doses (150 to 300 mcg) unless a provider is managing it.
Things to know: High-dose iodine can trigger or worsen autoimmune thyroid disease, especially without selenium. Many people on salt-free, dairy-free, seafood-free diets are quietly short.
Manganese, molybdenum, chromium (the minor ones)
Manganese: Needed by the mitochondrial superoxide dismutase, by the enzyme that makes glutamine in the brain, by PEPCK, and by the sulfation of connective tissue. Low: poor glucose control, bone and joint problems, poor antioxidant defense. High (welders, well water): a Parkinson's-like syndrome. Test: whole-blood manganese. Form: food (tea, nuts, whole grains, leafy greens); supplement rarely needed beyond 2 to 5 mg.
Molybdenum: Needed by sulfite oxidase (which clears sulfites) and xanthine oxidase. Low: sulfite sensitivity (wine, dried fruit headaches), sulfur food intolerance. Test: urinary sulfite (strips) as a functional clue. Form: 150 to 300 mcg molybdenum glycinate when sulfite-sensitive.
Chromium: Supports insulin signaling, though it is no longer considered an essential cofactor. Low: poor glucose control, sugar cravings. Test: none reliable. Form: chromium picolinate 200 to 400 mcg as a second-tier blood sugar lever.
Calcium, potassium, sodium (the electrolytes)
Calcium: Bone, muscle contraction, nerve signaling. Low: cramps, tingling around the mouth, bone loss. Test: serum calcium is tightly regulated and nearly always normal; bone density and PTH are the real readouts. Form: food (dairy, sardines with bones, greens) over supplements; calcium supplements without magnesium and K2 associate with arterial calcification.
Potassium: Nerve and muscle function, blood pressure. Low: weakness, cramps, palpitations, constipation. Test: serum potassium, which drops only late; low magnesium causes low potassium that will not correct. Form: food (potatoes, beans, avocado, greens, bananas); supplements are regulated for a reason.
Sodium: Blood volume and nerve signaling. Low: dizziness on standing, headache, fatigue, craving salt; common in POTS and in anyone sweating a lot on a "healthy" low-salt diet. Test: serum sodium stays normal; it is a volume question. Form: salt your food; 6 to 10 g of salt a day in POTS unless a provider says otherwise.
Part 4: The fats
Omega-3 (EPA and DHA)
What they do: DHA is about a third of the fat in nerve membranes and the retina; EPA and DHA make the resolvins and protectins that switch inflammation off; both lower triglycerides and calm mast cells.
Running low: Dry skin and eyes, poor concentration, low mood, joint stiffness, worse PMS, slow recovery from exercise, high triglycerides.
Deficient: Scaly dermatitis, visual and cognitive problems, in people with no dietary source for years.
Testing: The omega-3 index (EPA plus DHA as a percent of red cell membrane fat). Standard: anything above 4 is "not deficient." Functional target: 8 percent or above, which is where the cardiovascular and cognitive outcomes live. Most Americans are at 4 to 5.
Best form: Small oily fish (sardines, herring, anchovies, mackerel, wild salmon) three times a week, or fish oil 2 g EPA plus DHA in the triglyceride or re-esterified triglyceride form (Carlson), always with a fat-containing meal (absorption roughly triples). Algal oil for vegans.
Things to know: Flaxseed and chia (ALA) convert to EPA at a few percent and to DHA at almost zero in most people; they are not a substitute. Fish oil on an empty stomach mostly passes through. Mercury is the reason to prefer small fish. Rancid fish oil is worse than none; it should not smell or repeat on you.
Omega-6 (linoleic acid, GLA, arachidonic acid)
What they do: Linoleic acid is essential in small amounts for skin and membranes. GLA (from evening primrose and borage) makes anti-inflammatory prostaglandins. Arachidonic acid makes the inflammatory ones and is also needed for brain development.
Running low: Essentially impossible on a modern diet for linoleic acid; GLA shortfall shows as dry skin, eczema, PMS, and inflammation that omega-3 alone does not fix.
Too much: The real problem. Industrial seed oils (soybean, corn, canola, sunflower, "vegetable oil") push linoleic acid intake far above anything in human history, tilt membranes toward inflammation, and are easily oxidized.
Testing: A red cell fatty acid panel (the same test as the omega-3 index) shows the omega-6 to omega-3 ratio and the AA to EPA ratio. Functional target: omega-6 to omega-3 under 4 to 1; AA to EPA under 3.
Best form: Cut seed oils; cook in olive oil, butter, ghee, tallow, or coconut oil. GLA 240 to 480 mg from borage or evening primrose when the delta-6-desaturase step is slow (the FADS variants, or symptoms above).
Phospholipids and the fat-soluble carriers
Phosphatidylcholine (above, under choline) and phosphatidylserine (100 to 300 mg at night for an overactive evening cortisol) are the structural fats of every membrane. Cholesterol is not a dietary essential but is the raw material for every steroid hormone and vitamin D; very low LDL (under 70 without a drug) associates with low hormone output, low mood, and poor stress tolerance, and is worth a question rather than a congratulation.
Part 5: The amino acids
You need all twenty amino acids, nine of which you cannot make. The ones that most often run short in the kinds of pictures on this site are not the classic essential ones; they are the "conditionally essential" ones your body can make but not fast enough under load.
Protein overall: The first question. Under about 1.2 g per kg body weight a day, and especially under 0.8, the shortfalls below are almost guaranteed. Signs: slow healing, hair and nail problems, loss of muscle, frequent infections, edema in extreme cases. Test: a plasma amino acid panel (fasting) shows which ones are low; albumin and prealbumin are late and inflammation-confounded.
Glycine
What it does: A third of collagen, the backbone of glutathione and creatine and heme, the body's main conjugation partner in the liver, and an inhibitory neurotransmitter that deepens sleep.
Running low: Poor sleep, poor collagen repair, low glutathione, elevated homocysteine that responds to glycine, poor detox tolerance.
Testing: Plasma amino acids; most adults are low relative to demand regardless.
Best form: Bone broth, collagen peptides 15 to 20 g, or glycine powder 3 to 5 g at night.
Things to know: The body cannot make enough glycine to cover heavy collagen turnover; the shortfall is estimated at several grams a day in a bendy person. Glycine is also what GNMT uses to burn off excess methyl groups, so it buffers methylation from both sides.
Taurine
What it does: Stabilizes membranes, regulates calcium in the heart and muscle, forms bile salts, calms the nervous system (GABA-like), and is an antioxidant in the mitochondria.
Running low: Palpitations, anxiety, poor fat digestion, poor exercise recovery, elevated blood pressure.
Testing: Plasma amino acids. Vegans and anyone with a CBS or transsulfuration slowdown run low.
Best form: Meat and seafood; taurine 1 to 3 g.
Methionine, cysteine, and the sulfur amino acids
What they do: Methionine starts the methylation cycle (it becomes SAMe). Cysteine is the limiting ingredient for glutathione and the source of sulfate and taurine.
Running low: Low glutathione, poor detox, low sulfate (connective tissue and hormone clearance), fatigue.
Testing: Plasma amino acids; RBC glutathione; homocysteine (high means the cycle is stalled; very low can mean methionine is short).
Best form: Protein first. NAC 600 to 1,200 mg for cysteine (not plain cysteine, which oxidizes). Methionine is rarely supplemented; too much raises homocysteine.
Things to know: Some people react badly to sulfur (NAC, MSM, garlic, eggs): bloating, headaches, worse histamine. That is usually a CBS, SUOX, or molybdenum story and the fix is to go slow, not to avoid sulfur forever.
Tryptophan and tyrosine (the neurotransmitter precursors)
Tryptophan makes serotonin and melatonin, and most of it becomes NAD. Running low: low mood, poor sleep, carb cravings, anxiety. Inflammation diverts it away from serotonin (the kynurenine shunt). Test: plasma tryptophan and the kynurenine to tryptophan ratio. Form: turkey, eggs, dairy, seeds; L-tryptophan 500 mg at night (my preference over 5-HTP, which bypasses regulation). Never with SSRIs without a prescriber.
Tyrosine makes dopamine, norepinephrine, and thyroid hormone. Running low: low motivation, poor focus, cold intolerance, low blood pressure. Needs iron, BH4, and copper to be used, so supplementing tyrosine into an iron or BH4 shortage does nothing. Form: 500 to 1,500 mg in the morning, only after iron and B6 are addressed.
Carnitine and creatine (made from amino acids)
Carnitine carries fat into the mitochondria. Made from lysine and methionine using SAMe, iron, vitamin C, and B6, so it falls whenever methylation or iron is short. Running low: fatigue, muscle weakness, poor fat burning, low blood sugar with fasting. Test: plasma free carnitine and an acylcarnitine profile. Form: red meat; acetyl-L-carnitine 1,000 to 2,000 mg in the morning.
Creatine buffers energy in muscle and brain, and making it consumes about 40 percent of your daily methyl groups. Running low (vegetarians, low-meat eaters, high methylation demand): fatigue, poor exercise recovery, brain fog. Test: none routine. Form: creatine monohydrate 5 g daily. Supplying it frees the methylation budget for everything else, which is why it sits at the top of most of my sequences.
Glutamine, arginine, and the gut and vessel amino acids
Glutamine is the fuel for the gut lining and immune cells; it runs low in illness and after surgery. Running low: leaky gut, poor immune recovery, sugar cravings. Form: 5 g in water, short-term, for mucosal repair.
Arginine and citrulline make nitric oxide. Running low (or ADMA high): poor circulation, erectile dysfunction, high blood pressure. Citrulline 3 g is better absorbed than arginine. Caution: arginine feeds herpes viruses and nitric oxide can worsen pooling in POTS.
Histidine makes histamine and carnosine; lysine opposes arginine (useful in viral reactivation) and is needed for carnitine and collagen; serine feeds the folate cycle and makes glycine.
Part 6: Things to know that cut across everything
"Normal" is a population average, not a target. The reference range is the middle 95 percent of whoever got tested, and the people getting tested are not well. Low-normal across five nutrients is a pattern, not five coincidences.
Blood is not tissue. Serum folate, serum B12, serum magnesium, serum zinc, serum calcium, and serum potassium all read "fine" while cells are short. Use the inside-the-cell test (RBC folate, RBC magnesium, MMA) or the functional test (homocysteine, EGRAC, transketolase) when the symptoms say deficiency and the serum says no.
Inflammation lies on both sides. CRP up means ferritin, copper, and ceruloplasmin read falsely high, and zinc, vitamin A, selenium, and B6 read falsely low. Always run a CRP with a nutrient panel.
Cofactors come in teams. B2 activates B6 and folate; magnesium activates thiamine and vitamin D; zinc activates B6 and moves vitamin A; copper moves iron; selenium activates thyroid hormone; vitamin C recycles E; glutathione recycles C. Fixing one in isolation often moves the bottleneck to its partner.
Medications are the most common cause. PPIs (B12, magnesium, iron, zinc), metformin (B12), oral contraceptives (B6, folate, zinc, magnesium), statins (CoQ10, vitamin K2), diuretics (magnesium, potassium, thiamine, zinc), antibiotics (K2, B vitamins via the gut), methotrexate and sulfasalazine (folate), nitrous oxide (B12), and alcohol (nearly everything).
Genes change the need. MTHFR raises the riboflavin and folate requirement; BCO1 variants mean beta-carotene is not vitamin A for you; FADS variants mean ALA will not become EPA; HFE variants mean iron is dangerous; TCN2 and FUT2 variants lower B12 uptake; the VDR and GC variants change your vitamin D dose. The gene reports on this site are built around exactly these.
One at a time, lowest dose, food first. It is the only way to learn what your body actually responds to.
Educational content written from a research perspective, not medical advice. I am a PhD scientist, not a physician, and I do not diagnose, treat, cure, or prevent disease. Several nutrients on this page (iron, copper, selenium, iodine, potassium, vitamin A, vitamin K) are harmful in excess and should be dosed to laboratory values with your own healthcare provider.
Framing
Nutrient status assessment in routine practice answers one question: is this person at risk of the classical deficiency syndrome? The reference intervals were set for that purpose and they do it adequately. They were not set to answer whether a cofactor-dependent enzyme is running near its Vmax, whether a hypomorphic variant is being rescued, or whether a tissue pool is adequate when the circulating pool is normal. The presentations on this site live in the gap between those two questions, and this page is the reference for reading that gap.
For each nutrient: the enzymes or structures it serves, the gradient from subclinical to severe deficiency, the assay that reflects tissue status (and why the routine assay often does not), reference and functional ranges, the form the literature supports, and the interpretive traps. Functional ranges are drawn from enzyme saturation studies, symptom thresholds, and outcome data; they are research positions, stated as such, for discussion with the person's clinician.
A general rule for the whole page: for any nutrient with a circulating pool buffered by a storage organ (B12, folate, magnesium, calcium, potassium, vitamin A, iron), the serum value is the last thing to move, and the functional or intracellular assay is what tracks the symptoms.
Part 1: Water-soluble vitamins
Thiamine (B1)
Biochemistry. As thiamine diphosphate (TPP, also called TDP), the cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain ketoacid dehydrogenase, and transketolase (pentose phosphate pathway, hence NADPH and ribose). Activation by thiamine pyrophosphokinase is magnesium-dependent. Uptake via SLC19A2 and SLC19A3; mitochondrial TPP import via SLC25A19.
Gradient. Subclinical: carbohydrate-provoked fatigue, lactate rise at low workloads, orthostatic tachycardia, anxiety, GI dysmotility, cold extremities. Clinical: dry beriberi (length-dependent polyneuropathy), wet beriberi (high-output failure, edema), Wernicke encephalopathy (ophthalmoplegia, ataxia, confusion; the full triad is present in a minority). Severe: Korsakoff syndrome, cardiovascular collapse. Precipitants: alcohol, bariatric surgery, hyperemesis, refeeding, loop diuretics, SIBO (bacterial thiaminases), high-carbohydrate low-nutrient diets.
Assessment.
| Assay | Reference | Functional target | Notes |
|---|---|---|---|
| Whole-blood TDP (HPLC) | about 70 to 180 nmol/L | upper half | Reflects erythrocyte TPP; the preferred direct assay |
| Erythrocyte transketolase activity coefficient (TPP effect) | under 15 percent normal, 15 to 25 marginal, over 25 deficient | under 15 percent | In vitro cofactor stimulation; detects functional insufficiency |
| Serum or plasma thiamine | varies | not useful | Reflects recent intake; insensitive to tissue status |
Forms. Benfotiamine 150 to 300 mg (lipid-soluble S-acyl derivative, higher tissue levels, the form with microvascular and neuropathy data); thiamine HCl 300 to 1,800 mg in the high-dose fatigue literature (Costantini series in fibromyalgia, IBD, Parkinson's); thiamine tetrahydrofurfuryl disulfide (TTFD) 50 to 100 mg when transporter-independent delivery is wanted (SLC19A2/3 variants, CNS targets).
Traps. Magnesium deficiency blocks activation. Thiamine status governs folate compartmentation through SLC19A1 (see folate). Refeeding without thiamine precipitates Wernicke's. Alcohol inhibits both intestinal uptake and hepatic storage.
Riboflavin (B2)
Biochemistry. As FMN and FAD: complexes I and II, the acyl-CoA dehydrogenases and ETF/ETFDH (all of beta-oxidation), MTHFR, MTRR, glutathione reductase, MAO-A and MAO-B, xanthine oxidase, pyridoxine-5-phosphate oxidase (which activates B6), and the kynurenine pathway. Conversion to FAD requires thyroid hormone (riboflavin kinase and FAD synthase are T3-responsive).
Gradient. Subclinical: angular stomatitis, glossitis, photophobia, migraine, unexplained histamine reactivity (MAO-B and DAO support), intolerance of methyl donors (MTHFR C677T is a FAD-binding defect), fatigue. Clinical: ariboflavinosis with seborrheic dermatitis, normocytic anemia, peripheral neuropathy. Severe: rarely isolated; multiple B deficiency.
Assessment.
| Assay | Reference | Functional target | Notes |
|---|---|---|---|
| Erythrocyte glutathione reductase activity coefficient (EGRAC) | under 1.2 replete; 1.2 to 1.4 marginal; over 1.4 deficient | under 1.2 | The validated functional assay |
| Plasma riboflavin | varies | upper half | Intake-sensitive, less useful |
Forms. Riboflavin-5-phosphate 25 to 100 mg; riboflavin 400 mg daily for migraine prophylaxis (the dose with randomized data). Riboflavin partially rescues MTHFR C677T homozygotes in intervention studies, lowering homocysteine and blood pressure in that genotype.
Traps. Hypothyroidism produces functional riboflavin deficiency. Riboflavin deficiency produces secondary B6 deficiency (PNPO is FMN-dependent) and secondary folate deficiency (MTHFR). Yellow urine indicates absorption, not excess.
Niacin (B3)
Biochemistry. As NAD and NADP: several hundred dehydrogenases, the sirtuins, PARPs, CD38. Synthesized de novo from tryptophan (requires B2, B6, iron; QPRT), salvaged from nicotinamide (NAMPT, strongly circadian), or built from nicotinic acid (NAPRT) or nicotinamide riboside (NMRK1).
Gradient. Subclinical: fatigue, mood symptoms, photosensitivity, impaired stress tolerance. Clinical: pellagra (photosensitive dermatitis, diarrhea, dementia); seen in alcoholism, carcinoid syndrome (tryptophan diverted to serotonin), Hartnup disease, isoniazid therapy, and severe tryptophan-poor diets. Severe: fatal without repletion.
Assessment. Urinary N1-methylnicotinamide and 2-pyridone (research assays); no reliable routine serum marker. Organic acids (quinolinate, kynurenine metabolites) indirectly reflect the de novo route.
Forms. Nicotinamide 250 to 500 mg (NAD precursor without flushing; inhibits sirtuins at gram doses); nicotinamide riboside 250 to 500 mg (NMRK route); nicotinic acid for lipid effects only, with flushing. Niacin clearance is methylation-dependent (NNMT consumes SAMe), which is why high-dose niacin depletes methyl groups and why nicotinic acid is used to abort methyl-donor overstimulation.
Pantothenate (B5)
Biochemistry. Coenzyme A and acyl carrier protein; every acyl transfer, the TCA cycle, fatty acid synthesis and oxidation, steroidogenesis.
Gradient. Deficiency is rare and seen in famine ("burning feet syndrome"); subclinical shortfall presents as fatigue, paresthesia, and acne. No routine assay. Pantethine 300 to 900 mg has modest lipid-lowering data; otherwise B5 is adequately supplied by any B complex and most diets.
Pyridoxine (B6)
Biochemistry. As pyridoxal-5-phosphate (PLP): over 140 reactions, including the aminotransferases, aromatic amino acid decarboxylase (dopamine, serotonin, histamine synthesis), glutamate decarboxylase (GABA), cystathionine beta-synthase and cystathionine gamma-lyase (transsulfuration), ALAS1 (heme), glycogen phosphorylase, SHMT, kynureninase, and ornithine decarboxylase. Activation by PNPO (FMN-dependent); tissue uptake requires dephosphorylation by alkaline phosphatase (zinc-dependent).
Gradient. Subclinical: anxiety, dream-recall changes, irritability, PMS, carpal tunnel, glossitis, histamine symptoms, folate- and B12-refractory hyperhomocysteinemia, kynurenine pathway shunting (xanthurenate on organic acids). Clinical: microcytic sideroblastic anemia, seborrheic dermatitis, cheilosis, depression, immune impairment, infantile seizures. Severe: seizures, peripheral neuropathy (deficiency and excess both cause it).
Assessment.
| Assay | Reference | Functional target | Notes |
|---|---|---|---|
| Plasma PLP | about 20 to 125 nmol/L (lab-dependent) | over 50 | Falls with inflammation, hypophosphatasia, high alkaline phosphatase |
| Urinary xanthurenic acid after tryptophan load | research | low | Functional; organic acids panel approximates |
| Homocysteine, post-methionine load | research | normal rise | Detects transsulfuration limitation |
Forms. PLP 25 to 50 mg. Pyridoxine HCl above 50 to 100 mg long term is associated with sensory neuropathy, mechanistically through competitive inhibition of PLP-dependent enzymes by the unphosphorylated vitamin; PLP does not share this liability at usual doses.
Traps. High plasma PLP with deficiency symptoms suggests failed cellular uptake (low alkaline phosphatase, zinc deficiency, inflammation). B2 and zinc deficiency produce functional B6 deficiency. Oral contraceptives, isoniazid, hydralazine, penicillamine, and alcohol lower PLP. Pyridoxine-responsive inborn errors (CBS deficiency, ALDH7A1 epilepsy) are the prototype of Km-variant cofactor rescue.
Biotin (B7)
Biochemistry. Cofactor for the five carboxylases (pyruvate carboxylase, acetyl-CoA carboxylase 1 and 2, propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase); recycled by biotinidase.
Gradient. Subclinical: alopecia, brittle nails, periorificial dermatitis, paresthesia. Clinical: the dermatitis and alopecia with depression, lethargy, hypotonia, organic aciduria; causes are biotinidase deficiency, raw egg white (avidin), anticonvulsants, prolonged TPN.
Assessment. Urinary 3-hydroxyisovalerate (rises with marginal deficiency); biotinidase activity when inherited deficiency is suspected. Plasma biotin is unreliable.
Forms. Biotin 1 to 5 mg. Supplemental biotin interferes with streptavidin-biotin immunoassays (TSH, free T4, troponin, hCG, and others), producing falsely low or high results depending on assay design; it must be stopped 48 to 72 hours before labs.
Folate (B9)
Biochemistry. One-carbon carrier: thymidylate and purine synthesis (DNA), remethylation of homocysteine via methionine synthase (as 5-MTHF), and DHFR-mediated salvage of BH4 from BH2. Dietary folates are reduced polyglutamates; folic acid is the oxidized synthetic monoglutamate, which must be reduced by DHFR (slow in humans, saturable at about 200 mcg per dose) before use. Cellular uptake via the reduced folate carrier (SLC19A1), the proton-coupled folate transporter (SLC46A1, intestinal), and folate receptor alpha (brain, placenta).
Gradient. Subclinical: fatigue, low mood, impaired concentration, hyperhomocysteinemia, glossitis, aphthous ulcers, macrocytosis without anemia. Clinical: megaloblastic anemia, diarrhea, neural tube defects. Severe: pancytopenia.
Assessment.
| Assay | Reference | Functional target | Notes |
|---|---|---|---|
| Serum folate | over about 3 to 4 ng/mL | over 10 ng/mL | Reflects recent intake; can be high with empty cells |
| RBC folate | over about 140 ng/mL (over about 300 nmol/L) | over about 440 ng/mL (over 1,000 nmol/L) | Three-month intracellular status; the better test |
| Homocysteine | under 15 micromol/L (lab) | under 9 | Functional readout of folate, B12, B2, B6, betaine |
| Unmetabolized folic acid | research | undetectable | Indicates DHFR saturation |
Forms. Folinic acid (5-formyl-THF, leucovorin) 400 to 800 mcg: enters as a reduced folate past DHFR, supports the THF pool and thymidylate synthesis, and reaches 5-MTHF only at the rate MTHFR allows, which makes it the form least likely to produce methyl trapping. L-5-methyltetrahydrofolate 400 to 1,000 mcg: bypasses MTHFR but can be consumed only by methionine synthase, so it accumulates when that step is limited (the methyl trapping post is here); it also rapidly raises monoamine synthesis via the BH4 salvage route, which is the probable mechanism of the fast mood and arousal response some people report. Folic acid is avoided: DHFR saturation leaves unmetabolized folic acid that competes at folate receptor alpha.
Traps. Three patterns need separating.
- High serum folate, low RBC folate. Folate is circulating but not entering cells. Causes: unmetabolized folic acid (not a substrate for the reduced folate carrier at useful affinity); reduced SLC19A1 expression or function (the common 80G>A variant modestly lowers transport); and, a mechanism I think is under-appreciated, thiamine insufficiency. SLC19A1 is an anion exchanger that moves reduced folates into the cell in exchange for intracellular organic phosphates, and thiamine pyrophosphate is a demonstrated transported substrate of this carrier (Zhao, Gao, and Goldman, 2001; the carrier mediates TPP efflux in exchange for folate influx). When intracellular TPP is low, the exchange gradient that drives folate import is weakened. The practical reading is that a persistent high-serum, low-RBC folate pattern is a reason to assess thiamine status before escalating folate dose, and that the two deficiencies travel together more often than their independent prevalence predicts.
- Normal folate, high homocysteine. Look downstream: B12 (methionine synthase), B2 (MTHFR and MTRR), B6 (CBS), betaine (BHMT), magnesium, or renal function.
- Folate repletion in unrecognized B12 deficiency. Corrects the anemia and allows the myelopathy to progress; B12 status (MMA) is established before folate loading.
Cobalamin (B12)
Biochemistry. Two human enzymes: methionine synthase (as methylcobalamin, cytosolic; remethylation and folate recycling) and methylmalonyl-CoA mutase (as adenosylcobalamin, mitochondrial; odd-chain fatty acid, isoleucine, valine, threonine, methionine, and cholesterol side-chain catabolism via propionyl-CoA). Absorption requires gastric acid and pepsin (release from food protein), intrinsic factor (parietal cells), the cubam receptor (ileum), and transcobalamin II for cellular delivery; the TCN2 776C>G variant lowers delivery efficiency. Intracellular processing by MMACHC removes the upper ligand from any form before the cofactors are made. Methionine synthase holds cob(I)alamin, which superoxide, nitric oxide, and peroxynitrite oxidize to inactive cob(II)alamin; reactivation requires MTRR and SAMe.
Gradient. Subclinical: fatigue, distal paresthesia, cognitive slowing, mood symptoms, subtle proprioceptive loss, elevated MMA and homocysteine, autonomic symptoms. Clinical: megaloblastic anemia, symmetric neuropathy, glossitis, depression, memory impairment; neurologic signs may precede hematologic ones by years, particularly when folate intake is high. Severe: subacute combined degeneration (dorsal columns and corticospinal tracts), dementia, psychosis, optic neuropathy; irreversible past a threshold.
Assessment.
| Assay | Reference | Functional target | Notes |
|---|---|---|---|
| Serum B12 | about 200 to 900 pg/mL | over 500 pg/mL | Insensitive; neuropathy documented at 200 to 400; falsely high in liver disease, myeloproliferative disease, and with anti-IF antibody interference; falsely normal with TCN1 (haptocorrin) binding |
| Holotranscobalamin | about 35 to 170 pmol/L | over 50 pmol/L | The bioavailable fraction; earliest marker to fall |
| Methylmalonic acid | under about 270 to 400 nmol/L (lab) | under 270 nmol/L | Specific functional marker for the mitochondrial cofactor; rises with renal impairment and SIBO (propionate) |
| Homocysteine | under 15 micromol/L | under 9 | Non-specific; also folate, B2, B6, betaine, renal |
Forms. Hydroxocobalamin plus adenosylcobalamin, 1,000 to 2,000 mcg sublingual daily; hydroxocobalamin 1 mg IM weekly for eight weeks then monthly when MMA is elevated, neurologic signs are present, or absorption is compromised. Hydroxocobalamin is the natural circulating form, is retained longer than cyanocobalamin, scavenges nitric oxide and cyanide, and is converted intracellularly to either coenzyme; adenosylcobalamin supplies the mitochondrial form directly; neither carries a methyl group. Methylcobalamin is appropriate for people with demonstrated methyl tolerance. Cyanocobalamin requires decyanation and is the least favored. About 1 to 2 percent of any oral dose is absorbed by passive diffusion independent of intrinsic factor, which is why high-dose oral therapy works in pernicious anemia.
Traps. Metformin (cubam-dependent uptake), PPIs and H2 blockers, nitrous oxide (irreversibly oxidizes the cob(I) center of methionine synthase; a single anesthetic exposure can precipitate myelopathy in a marginal person), plant-based diets, atrophic gastritis, ileal disease, and FUT2 non-secretor status all lower B12. Oxidative stress produces functional deficiency at normal serum levels. Evening dosing is associated with sleep disruption in a subset (cobalamin modulates melatonin rhythm).
Choline
Biochemistry. Phosphatidylcholine (membranes, VLDL assembly, bile), sphingomyelin, acetylcholine, and betaine (BHMT remethylation; a methyl donor independent of folate). Endogenous synthesis via PEMT spends three SAMe per phosphatidylcholine and is estrogen-induced; PEMT variants and post-menopausal status raise the dietary requirement.
Gradient. Subclinical: hepatic steatosis, elevated homocysteine, cognitive complaints, myalgia with raised CK. Clinical: fatty liver and muscle damage within weeks in controlled depletion studies; most adults fall below the adequate intake (425 to 550 mg).
Assessment. No validated routine marker; plasma choline is intake-sensitive. Status is inferred from intake (eggs, liver, meat), liver fat, CK, and homocysteine.
Forms. Eggs (about 150 mg each) and liver; phosphatidylcholine (sunflower lecithin) 1,200 to 2,400 mg; citicoline 250 to 500 mg; alpha-GPC 300 to 600 mg when the cholinergic target dominates. Supplying phosphatidylcholine suppresses PEMT and spares SAMe, which is the basis of the methyl-sparing sequencing used across this site.
Part 2: Fat-soluble vitamins
Vitamin A
Biochemistry. Retinal (vision), retinoic acid (nuclear receptor signaling for epithelial differentiation, immune regulation, and as the RXR partner for vitamin D, thyroid, and PPAR receptors). Beta-carotene conversion by BCO1 is highly variable (common variants reduce it by half or more); transport from the liver requires retinol-binding protein, whose synthesis is zinc-dependent.
Gradient. Subclinical: impaired dark adaptation, xerophthalmia, follicular hyperkeratosis, recurrent respiratory and urinary infection, impaired wound healing. Clinical: night blindness, Bitot's spots, keratomalacia, measles mortality. Severe: corneal destruction, blindness.
Assessment. Serum retinol (reference about 30 to 65 mcg/dL; held by hepatic release until stores are nearly exhausted; falls as a negative acute phase reactant) with RBP and CRP. Functional target: upper half with normal CRP.
Forms. Preformed retinol from liver and cod liver oil; retinyl palmitate 3,000 to 5,000 IU when supplementing; beta-carotene is not a reliable source in BCO1 low-converters. Teratogenic above 10,000 IU daily in pregnancy.
Traps. Zinc deficiency traps retinol in the liver. Vitamin A and D compete for and cooperate at RXR; high-dose monotherapy of either produces relative deficiency of the other. Inflammation lowers serum retinol independent of stores.
Vitamin D
Biochemistry. 25-hydroxylation in the liver (CYP2R1), 1-alpha-hydroxylation in the kidney and in immune and other tissues (CYP27B1), catabolism by CYP24A1. Calcitriol regulates calcium and phosphate, and through the VDR the expression of several hundred genes in immune cells, muscle, beta cells, and mast cells (it suppresses mast cell activation and IgE-mediated degranulation). Activation requires magnesium at both hydroxylases.
Gradient. Subclinical: fatigue, myalgia, seasonal mood change, recurrent infection, heightened atopic and mast cell reactivity, insulin resistance. Clinical: osteomalacia (bone pain, proximal weakness), rickets, secondary hyperparathyroidism. Severe: fractures, hypocalcemic tetany and seizures in infants.
Assessment.
| Assay | Reference | Functional target | Notes |
|---|---|---|---|
| 25-OH vitamin D | over 20 to 30 ng/mL "sufficient" | 50 to 70 ng/mL | Outcome data for immune, musculoskeletal, and mortality endpoints cluster above 40 |
| 1,25-OH vitamin D | hormone assay | not a status marker | Rises in deficiency (PTH-driven) and in granulomatous disease |
| PTH, calcium, phosphate | normal | Confirm functional adequacy; a normal PTH with a low 25-OH-D in a GC (binding protein) variant carrier suggests measured deficiency without functional deficiency |
Forms. D3 2,000 to 5,000 IU daily with K2 (MK-7 100 to 200 mcg) and a fat-containing meal, rechecked at 12 weeks; dose scales with body weight, skin pigmentation, and baseline. Carlson D3 4,000 IU with K2 MK-7, or Thorne D/K2 liquid.
Traps. Magnesium deficiency limits activation and is the usual explanation for symptomatic worsening on vitamin D. GC gene variants alter the measured total 25-OH-D without changing free vitamin D. CYP24A1 loss-of-function produces hypercalcemia on modest doses; check calcium when starting.
Vitamin E
Biochemistry. Alpha-tocopherol is the principal lipid-phase chain-breaking antioxidant; gamma-tocopherol scavenges reactive nitrogen species; tocotrienols have distinct effects on HMG-CoA reductase, inflammation, and neuroprotection. Hepatic alpha-tocopherol transfer protein (TTPA) selects alpha-tocopherol for export and lets the other forms go; high-dose alpha-tocopherol depletes gamma-tocopherol and tocotrienols.
Gradient. Subclinical: impaired exercise recovery, increased lipid peroxidation (F2-isoprostanes), mild sensory symptoms. Clinical: spinocerebellar ataxia, peripheral neuropathy with loss of proprioception, retinopathy, hemolysis; seen in fat malabsorption, abetalipoproteinemia, TTPA mutations.
Assessment. Serum alpha-tocopherol corrected for total lipids (ratio to cholesterol plus triglycerides); gamma-tocopherol where available. Functional target: alpha-tocopherol to lipid ratio in the upper half.
Forms. Mixed tocotrienols with mixed tocopherols (Procapsin) 100 to 200 mg; avoid isolated high-dose synthetic dl-alpha-tocopherol. Ascorbate regenerates the tocopheroxyl radical; glutathione regenerates ascorbate.
Vitamin K
Biochemistry. Cofactor for gamma-glutamyl carboxylase, which activates the clotting factors (K1, hepatic) and the extrahepatic Gla proteins: osteocalcin (bone mineralization), matrix Gla protein (arterial calcification inhibition), Gas6, and others (K2 as MK-4 and MK-7). Recycled by VKORC1 (the warfarin target); MK-4 is synthesized from K1 and menadione by UBIAD1 in extrahepatic tissue.
Gradient. Subclinical: easy bruising, menorrhagia, low bone density, vascular calcification on imaging, elevated undercarboxylated osteocalcin. Clinical: coagulopathy. Severe: hemorrhage.
Assessment. INR detects only severe hepatic K1 deficiency. Undercarboxylated osteocalcin (ucOC) and dephospho-uncarboxylated matrix Gla protein (dp-ucMGP) are the functional K2 markers; PIVKA-II for K1.
Forms. K2 as MK-7 100 to 200 mcg daily with vitamin D; MK-4 at 45 mg in the Japanese osteoporosis literature. Food: natto, hard and fermented cheeses, egg yolk, liver.
Traps. Warfarin requires steady, not absent, intake and prescriber management. Antibiotics, fat malabsorption, and bile acid sequestrants lower status. Vitamin D supplementation without K2 raises Gla protein synthesis without the means to activate it.
Part 3: Vitamin C and the minerals
Ascorbate
Biochemistry. Reducing cofactor for the Fe(II)/2-oxoglutarate dioxygenases (prolyl and lysyl hydroxylases of collagen; the two hydroxylases of carnitine synthesis; HIF prolyl hydroxylases; TET demethylases), for dopamine beta-hydroxylase (copper enzyme), and for BH4 and tocopherol regeneration; enhances non-heme iron absorption by reducing Fe(III); modulates mast cell histamine release and supports DAO.
Gradient. Subclinical: easy bruising, gingival bleeding, delayed wound healing, fatigue, arthralgia, corkscrew hairs, recurrent infection, reduced carnitine synthesis. Clinical: scurvy (perifollicular hemorrhage, gingivitis, reopening of old wounds, anemia, depression); seen with absent fresh produce, alcoholism, bariatric surgery, dialysis. Severe: hemorrhage, death.
Assessment. Plasma ascorbate (fasting, protected from oxidation; reference about 23 to 85 micromol/L; under 11 deficient; functional target over 50). Leukocyte ascorbate reflects tissue stores but is rarely available.
Forms. Liposomal ascorbate 1,000 mg or ascorbic acid 500 mg two to three times daily (saturable intestinal transport favors divided doses). Requirements rise with smoking, oxidative stress, inflammation, and connective tissue repair demand.
Traps. Raises iron absorption (desirable with low ferritin; harmful in HFE hemochromatosis). High doses raise urinary oxalate in susceptible people and interfere with some glucose meters and fecal occult blood tests.
Magnesium
Biochemistry. Mg-ATP is the substrate for every kinase and ATPase; required by thiamine pyrophosphokinase, both vitamin D hydroxylases, methionine adenosyltransferase, glucokinase, the insulin receptor kinase, guanylate cyclase, and over 300 further enzymes; physiological NMDA channel blocker; stabilizes mast cells. Intestinal uptake via TRPM6 (acid-dependent, PPI-sensitive) and paracellular routes; renal reabsorption via CLDN16/19 and TRPM6.
Gradient. Subclinical: cramps, fasciculations, eyelid twitch, insomnia, anxiety, constipation, migraine, palpitations, PMS, carbohydrate craving, reduced stress tolerance; the most prevalent subclinical deficiency in the presentations on this site. Clinical: tetany, arrhythmia, hypokalemia and hypocalcemia refractory until magnesium is repleted, seizures. Severe: torsades, death.
Assessment.
| Assay | Reference | Functional target | Notes |
|---|---|---|---|
| Serum magnesium | 1.7 to 2.4 mg/dL | over 2.1 | Under 1 percent of body magnesium; held by bone and muscle efflux; falls only in severe depletion |
| RBC magnesium | about 4.2 to 6.8 mg/dL | over 5.5 | Intracellular; better correlated with symptoms |
| Magnesium loading (retention) test | retention under 20 percent replete | Gold standard; rarely performed | |
| Ionized magnesium | research | Available in some labs |
Forms. Glycinate or bisglycinate at night (sleep, anxiety), malate by day (TCA intermediate, fatigue; Seeking Health Magnesium Malate powder), citrate for constipation, threonate for CNS targets, 300 to 400 mg elemental titrated to bowel tolerance. Oxide has poor bioavailability.
Traps. PPIs, loop and thiazide diuretics, alcohol, hyperglycemia, cisplatin, cetuximab, and sweating all deplete. Calcium supplementation without magnesium worsens the ratio. Vitamin D repletion without magnesium fails or produces symptoms.
Zinc
Biochemistry. Catalytic or structural in roughly 300 enzymes and 2,000 transcription factors: carbonic anhydrase (gastric acid), alkaline phosphatase (B6 activation), RBP synthesis (vitamin A transport), SOD1 and SOD3, metallothionein, insulin hexamer storage, the zinc-finger transcription factors, thymulin (T cell function), and taste and smell receptors.
Gradient. Subclinical: recurrent infection, delayed wound healing, leukonychia, hypogeusia and hyposmia, acne, anorexia, telogen effluvium, hypochlorhydria. Clinical: acrodermatitis enteropathica pattern (periorificial and acral dermatitis), diarrhea, alopecia, severe infection, growth failure, hypogonadism. Severe: immune collapse.
Assessment. Plasma or serum zinc, fasting, morning (reference about 70 to 120 mcg/dL; functional target upper half); falls with inflammation, hypoalbuminemia, and postprandially. Low alkaline phosphatase is a supporting clue. Always measured with copper.
Forms. Zinc picolinate or bisglycinate 15 to 30 mg balanced with copper 1 to 2 mg (Jarrow Zinc Balance). Phytate, PPIs, and high-dose iron reduce absorption.
Traps. Zinc induces enterocyte metallothionein, which sequesters copper and produces copper deficiency within months of unopposed supplementation; the resulting anemia, neutropenia, and myeloneuropathy mimic B12 deficiency. This is the most common supplement-induced deficiency in the people I have worked with.
Copper
Biochemistry. Lysyl oxidase (collagen and elastin cross-linking), dopamine beta-hydroxylase (norepinephrine synthesis), cytochrome c oxidase (complex IV), SOD1 and SOD3, ceruloplasmin and hephaestin (ferroxidases required for iron export), tyrosinase, diamine oxidase (gut histamine degradation), and peptidylglycine alpha-amidating monooxygenase (neuropeptide maturation). Hepatic handling by ATP7B (Wilson's disease).
Gradient. Subclinical: fatigue, orthostatic hypotension (norepinephrine deficit), histamine intolerance, easy bruising, premature graying, impaired wound healing, iron-refractory anemia. Clinical: anemia with neutropenia, myeloneuropathy indistinguishable from B12 deficiency, osteoporosis; causes are zinc excess, bariatric surgery, chronic high-dose ascorbate, celiac disease, zinc-containing denture adhesives. Severe: irreversible myelopathy.
Assessment. Serum copper (reference about 70 to 140 mcg/dL) with ceruloplasmin (about 20 to 35 mg/dL); both are positive acute phase reactants and rise with estrogen, so a normal copper in an inflamed or estrogen-exposed person may mask deficiency; a copper to zinc ratio near 1 is the functional target; an elevated ratio suggests inflammation or zinc deficiency. Low ceruloplasmin with low copper raises Wilson's; low ceruloplasmin with high free copper confirms it.
Forms. Liver (about 4 mg per ounce) and oysters; copper bisglycinate 1 to 2 mg only when measured low after dietary liver, never with high-dose zinc.
Traps. Copper excess is hepatotoxic and neurotoxic; the ATP7B variant frequency makes this a test-then-supplement mineral. Iron-refractory anemia is a copper question before it is an iron question.
Iron
Biochemistry. Hemoglobin and myoglobin; the Fe-S clusters of complexes I, II, and III and aconitase; tyrosine hydroxylase and tryptophan hydroxylase (monoamine synthesis); the Fe(II)/2-OG dioxygenases (collagen, carnitine, HIF); thyroid peroxidase; ribonucleotide reductase; the cytochromes P450. Absorption via DMT1 (non-heme, acid- and ascorbate-dependent) and HCP1 (heme); export via ferroportin, which hepcidin degrades; hepcidin rises with iron stores and with IL-6.
Gradient. Subclinical (iron deficiency without anemia): fatigue, restless legs, telogen effluvium, cold intolerance, orthostatic tachycardia, reduced exercise capacity, cognitive slowing, pagophagia, brittle nails, thyroid conversion impairment. Clinical: microcytic hypochromic anemia, koilonychia, glossitis, angular cheilitis. Severe: high-output failure.
Assessment.
| Assay | Reference | Functional target | Notes |
|---|---|---|---|
| Ferritin | about 15 to 150 ng/mL (women), 30 to 400 (men) | 50 to 100; over 75 with restless legs | Acute phase reactant; interpret with CRP; under 30 is deficient regardless of hemoglobin |
| Transferrin saturation | 15 to 50 percent | 25 to 40 percent | Low with deficiency; over 45 raises HFE hemochromatosis |
| Soluble transferrin receptor | lab | normal | Rises in tissue deficiency; not affected by inflammation |
| Hemoglobin, MCV, RDW | Late; RDW rises first |
Forms. Heme iron from red meat and liver (absorption 15 to 35 percent versus 2 to 10 for non-heme); iron bisglycinate 25 to 50 mg every other day with ascorbate, since daily dosing raises hepcidin and blunts next-day absorption; recheck ferritin and saturation at 12 weeks; IV iron through a clinician when oral therapy fails, ferritin is very low with symptoms, or absorption is compromised.
Traps. Never supplement without ferritin and saturation; HFE C282Y and H63D are common and iron overload is as damaging as deficiency. Hypochlorhydria, PPIs, tannins and calcium with meals, celiac disease, and gut inflammation impair absorption. Copper deficiency produces iron-refractory anemia. Iron deficiency alone can produce an orthostatic tachycardia phenotype, impaired T4 to T3 conversion, and reduced monoamine synthesis.
Selenium
Biochemistry. Selenocysteine in about 25 selenoproteins: glutathione peroxidases 1 to 4 (GPX4 blocks ferroptosis), thioredoxin reductases, deiodinases 1 to 3 (T4 to T3 conversion and T3 inactivation), selenoprotein P (transport), and methionine sulfoxide reductase.
Gradient. Subclinical: low free T3 with normal TSH, elevated thyroid antibodies, fatigue, impaired antioxidant capacity, myalgia. Clinical: Keshan cardiomyopathy, Kashin-Beck osteoarthropathy, hypothyroidism (in low-selenium regions and TPN). Severe: cardiomyopathy.
Assessment. Plasma or serum selenium (reference about 70 to 150 mcg/L; functional target 120 to 150, at which selenoprotein P is saturated); glutathione peroxidase activity.
Forms. Two Brazil nuts daily (content varies ten-fold with soil); selenomethionine 100 to 200 mcg. Toxicity (selenosis: alopecia, nail dystrophy, neuropathy) above about 400 mcg daily.
Traps. Iodine supplementation without selenium repletion worsens autoimmune thyroiditis; selenium modestly lowers TPO antibodies in several trials.
Iodine
Biochemistry. Thyroxine and triiodothyronine synthesis via thyroid peroxidase (heme and iron dependent); extrathyroidal iodine in breast, ovary, gastric mucosa, and salivary tissue (sodium-iodide symporter expression).
Gradient. Subclinical: fatigue, cold intolerance, weight gain, fibrocystic breast change, impaired concentration, mild goiter. Clinical: goiter, hypothyroidism, neurodevelopmental impairment in offspring. Severe: cretinism, myxedema.
Assessment. Urinary iodine concentration (spot, adjusted for creatinine, or 24-hour; reference 100 to 300 mcg/L; functional target 100 to 200); thyroglobulin as a longer-term marker.
Forms. Seaweed, seafood, eggs, dairy, iodized salt; supplemental iodine 150 to 300 mcg; higher doses only under clinical supervision.
Traps. Excess iodine precipitates or worsens autoimmune thyroiditis (Wolff-Chaikoff escape failure), particularly with selenium insufficiency. Salt-restricted, dairy-free, seafood-free diets produce quiet deficiency.
Manganese, molybdenum, chromium
Manganese. SOD2 (mitochondrial superoxide dismutase), glutamine synthetase (ammonia detoxification in astrocytes), PEPCK, arginase, pyruvate carboxylase, and the glycosyltransferases of proteoglycan synthesis. Deficiency: impaired glucose tolerance, bone and cartilage abnormalities, reduced antioxidant capacity. Excess (welding fume, well water, TPN): manganism, a parkinsonian syndrome. Whole-blood manganese (reference about 4 to 15 mcg/L). Dietary sources (tea, nuts, whole grains, leafy greens) suffice; supplementation 2 to 5 mg only when indicated.
Molybdenum. Cofactor (as molybdopterin) for sulfite oxidase, xanthine oxidase, aldehyde oxidase, and mARC. Deficiency or SUOX hypofunction: sulfite sensitivity (wine, dried fruit, cured meat headache and flushing), sulfur food intolerance, elevated urinary sulfite, low uric acid. Urinary sulfite strips as a functional screen; plasma molybdenum rarely useful. Molybdenum glycinate 150 to 300 mcg.
Chromium. Removed from the obligate-cofactor list after the chromodulin model failed replication; modest and inconsistent effects on insulin sensitivity in trials. No reliable status assay. Chromium picolinate 200 to 400 mcg as a second-tier agent.
Calcium, potassium, sodium
Calcium. Serum calcium is homeostatically fixed and uninformative about intake; PTH, 25-OH-D, and bone density are the readouts. Dietary calcium (dairy, sardines with bones, leafy greens) is preferred; supplemental calcium without magnesium and K2 associates with vascular calcification in several cohorts.
Potassium. Serum potassium falls late; hypomagnesemia produces refractory hypokalemia (ROMK channel). Food sources (potato, legumes, avocado, leafy greens); supplementation is prescriber-managed because of arrhythmia risk.
Sodium. Serum sodium is osmoregulated and does not reflect total body sodium or volume. In orthostatic intolerance, 6 to 10 g sodium chloride with 2 to 3 L fluid daily is the volume-expansion standard, contraindicated in renal disease, heart failure, and uncontrolled hypertension.
Part 4: Fatty acids and phospholipids
Omega-3 (EPA, DHA)
Biochemistry. DHA constitutes 30 to 40 percent of neuronal and retinal membrane acyl chains and governs membrane fluidity and receptor function; EPA and DHA are precursors of resolvins, protectins, and maresins (specialized pro-resolving mediators that terminate inflammation) and compete with arachidonic acid at COX and LOX; both lower hepatic VLDL output and triglycerides, and stabilize mast cells. ALA conversion to EPA is 5 to 10 percent and to DHA under 1 percent in most adults, lower in men and in FADS1/2 minor-allele carriers.
Gradient. Subclinical: xerosis, dry eye, impaired concentration, low mood, arthralgia, dysmenorrhea, slow exercise recovery, hypertriglyceridemia, omega-3 index under 6. Clinical: scaly dermatitis, visual and neurocognitive impairment with prolonged absence of intake.
Assessment. Omega-3 index (EPA plus DHA as percent of erythrocyte membrane fatty acids; under 4 high risk, 4 to 8 intermediate, over 8 the functional target associated with lowest cardiovascular and cognitive risk); full erythrocyte fatty acid panel including the AA to EPA ratio (functional target under 3) and omega-6 to omega-3 ratio (under 4).
Forms. Small oily fish three times weekly; fish oil 2 to 4 g EPA plus DHA as re-esterified triglyceride (Carlson), with a fat-containing meal (bioavailability roughly triples with concurrent fat because absorption is bile- and micelle-dependent); algal oil for vegans. Peroxide value and smell matter; oxidized fish oil is pro-inflammatory.
Traps. ALA sources do not substitute. Mercury scales with trophic level, hence small fish. Empty-stomach dosing is largely wasted.
Omega-6 (linoleic acid, GLA, arachidonic acid)
Biochemistry. Linoleic acid is the essential precursor; desaturation (FADS2, delta-6) and elongation yield GLA, DGLA (anti-inflammatory 1-series prostaglandins), and arachidonic acid (2-series prostaglandins, leukotrienes, and also a required structural lipid in brain and a precursor of lipoxins). Delta-6-desaturase is rate-limiting and is inhibited by insulin resistance, alcohol, trans fats, and zinc, magnesium, B6, and vitamin C insufficiency.
Gradient. Linoleic acid deficiency is practically unattainable on a Western diet; the clinical problem is excess from industrial seed oils (linoleic acid intake several-fold above historical levels, membrane enrichment, oxidized linoleic acid metabolites). Functional GLA shortfall presents as xerosis, eczema, PMS, and omega-3-unresponsive inflammation.
Assessment. Erythrocyte fatty acid panel: linoleic acid percentage, omega-6 to omega-3 ratio, AA to EPA ratio, DGLA to AA ratio.
Forms. Remove seed oils; cook in olive oil, butter, ghee, tallow, or coconut oil. GLA 240 to 480 mg from borage or evening primrose when delta-6-desaturase is limited.
Phospholipids and sterols
Phosphatidylcholine (above) and phosphatidylserine (100 to 300 mg at bedtime; blunts evening cortisol in several small trials) are the structural phospholipids of all membranes; phosphatidylethanolamine is the PEMT substrate. Cholesterol is not a dietary essential, but very low LDL in the absence of lipid-lowering therapy (under about 70 mg/dL) associates with reduced steroidogenesis, low vitamin D, mood symptoms, and impaired stress tolerance, and warrants evaluation (malabsorption, hyperthyroidism, chronic inflammation, hypobetalipoproteinemia) rather than reassurance.
Part 5: Amino acids
Protein adequacy
Below about 1.2 g/kg/day (and certainly below the 0.8 g/kg RDA) the conditionally essential amino acids below cannot be supplied under load. Signs: delayed healing, telogen effluvium, nail dystrophy, sarcopenia, recurrent infection, edema in extremis. Assessment: fasting plasma amino acid panel (the only direct measure; albumin and prealbumin are late and inflammation-confounded); urinary organic acids for pathway-level readouts.
Glycine
Roles. A third of collagen; a constituent of glutathione, creatine, heme, and purines; the glycine conjugation substrate in phase II; the GNMT sink that disposes of excess SAMe; an inhibitory neurotransmitter and NMDA co-agonist. Endogenous synthesis (SHMT from serine; choline via sarcosine) is estimated to fall short of demand by several grams daily, more under collagen turnover. Shortfall: poor sleep, impaired collagen repair, low glutathione, glycine-responsive hyperhomocysteinemia, poor xenobiotic tolerance. Assessment: plasma glycine and serine; GSH. Forms: collagen peptides 15 to 20 g; glycine 3 to 5 g at bedtime (lowers core temperature, increases slow-wave sleep in controlled studies).
Taurine
Roles. Membrane stabilization, calcium handling in myocardium and skeletal muscle, bile acid conjugation, mitochondrial antioxidant (tRNA modification), osmolyte, GABA-A and glycine receptor agonist. Synthesized from cysteine (CDO, CSAD; B6-dependent); low in vegans and in transsulfuration hypofunction. Shortfall: palpitations, anxiety, impaired fat digestion, poor recovery, hypertension. Assessment: plasma taurine. Forms: meat and seafood; taurine 1 to 3 g.
Methionine, cysteine, and the sulfur pool
Roles. Methionine is the SAMe precursor (MAT, magnesium-dependent). Cysteine is rate-limiting for glutathione (GCL), the source of taurine and sulfate (PAPS for sulfation of glycosaminoglycans, hormones, and xenobiotics), and a coenzyme A constituent; supplied by transsulfuration (CBS, CTH; B6 and heme dependent; CBS activated by SAMe) and by cystine import (SLC7A11). Shortfall: low glutathione, impaired phase II, low sulfate, fatigue. Assessment: plasma amino acids, RBC glutathione, GSH:GSSG, homocysteine (high indicates stalled remethylation or transsulfuration; very low can indicate methionine or CBS overactivity). Forms: protein; NAC 600 to 1,200 mg (cysteine itself oxidizes); methionine supplementation is rarely indicated and raises homocysteine. Traps: sulfur intolerance (NAC, MSM, alliums, crucifers, eggs) usually reflects CBS, SUOX, or molybdenum limitation and is addressed by slow titration and cofactor repletion rather than permanent avoidance.
Tryptophan and tyrosine
Tryptophan. Serotonin and melatonin via TPH (BH4, iron) and AADC (PLP); over 90 percent is catabolized via the kynurenine pathway (IDO1 induced by interferon-gamma, TDO by cortisol) toward NAD or, under inflammation, toward quinolinate and kynurenic acid. Shortfall or diversion: low mood, insomnia, carbohydrate craving, anxiety. Assessment: plasma tryptophan, kynurenine to tryptophan ratio, urinary kynurenate and quinolinate. Forms: L-tryptophan 500 mg at bedtime (preferred over 5-HTP, which bypasses TPH regulation and raises peripheral serotonin); not combined with serotonergic drugs without prescriber oversight.
Tyrosine. Dopamine and norepinephrine via TH (BH4, iron) and DBH (copper, ascorbate); thyroid hormone. Shortfall: apathy, impaired focus, cold intolerance, hypotension. Forms: 500 to 1,500 mg in the morning, only after iron, copper, BH4 cofactors (folate, ascorbate), and B6 are addressed; otherwise inert.
Carnitine and creatine
Carnitine. Mitochondrial import of long-chain fatty acids (CPT1, CACT, CPT2); acyl buffering and export of toxic acyl-CoAs. Synthesized from trimethyllysine (three SAMe per molecule) via two Fe/2-OG/ascorbate hydroxylases and a PLP-dependent aldolase, so it falls with methylation debt, iron, ascorbate, or B6 insufficiency, and with SLC22A5 transporter variants; depleted by valproate, pivalate antibiotics, and dialysis. Shortfall: fatigue, myopathy, hypoketotic hypoglycemia with fasting, hypertriglyceridemia. Assessment: plasma free carnitine (reference about 25 to 55 micromol/L), acylcarnitine profile, acyl to free ratio. Forms: red meat; acetyl-L-carnitine 1,000 to 2,000 mg in the morning (also an acetyl donor for acetylcholine); L-carnitine tartrate for muscle.
Creatine. Phosphocreatine buffering in muscle, brain, and secretory cells; synthesis (AGAT, GAMT) consumes roughly 40 percent of daily SAMe. Shortfall: vegetarians and low-meat eaters, high methylation demand, GAMT or AGAT variants: fatigue, poor recovery, cognitive complaints. Assessment: no routine assay; plasma guanidinoacetate in inborn errors. Forms: creatine monohydrate 5 g daily; supplying it suppresses AGAT by feedback and releases SAMe, which is why it leads most of the sequences on this site.
Glutamine, arginine, citrulline, lysine, histidine, serine
Glutamine: enterocyte and lymphocyte fuel, glutathione constituent (via glutamate), ammonia carrier; falls in critical illness and after surgery; 5 g daily for mucosal repair, short-term. Arginine and citrulline: NO synthesis (NOS3; BH4 dependent), urea cycle, creatine synthesis; citrulline 3 g raises plasma arginine more effectively than arginine itself; ADMA is the endogenous NOS inhibitor and a marker of oxidative stress; caution with arginine in herpesvirus reactivation (viral replication is arginine-dependent) and with NO donors in orthostatic pooling. Lysine: carnitine and collagen precursor; opposes arginine uptake (used in herpesvirus reactivation at 1 to 3 g). Histidine: histamine (HDC, PLP) and carnosine precursor; histidine supplementation raises histamine in sensitive people. Serine: the main one-carbon donor to the folate cycle via SHMT and the glycine precursor; low serine is a cause of low glycine and impaired remethylation.
Part 6: Cross-cutting interpretive rules
Reference intervals are population descriptors, not physiological targets. The central 95 percent of a tested population (which skews unwell) defines "normal." Clustered low-normal values across a pathway are a pattern, not independent noise.
Circulating is not intracellular. Serum folate, B12, magnesium, zinc, calcium, potassium, and vitamin A are all buffered or regulated and can read normal with depleted tissue. Use the intracellular assay (RBC folate, RBC magnesium) or the functional assay (MMA, homocysteine, EGRAC, transketolase TPP effect, holoTC, ucOC, omega-3 index) when the presentation and the serum disagree.
Inflammation distorts in both directions. Positive acute phase reactants (ferritin, copper, ceruloplasmin) read falsely high; negative acute phase reactants (zinc, retinol, selenium, PLP, albumin-bound analytes) read falsely low. Interpret every nutrient panel against a concurrent CRP.
Cofactors act in networks. FMN activates B6; FAD runs MTHFR and MTRR; magnesium activates thiamine and vitamin D; zinc activates B6 and mobilizes vitamin A; copper mobilizes iron; selenium activates T3; ascorbate regenerates tocopherol and BH4; glutathione regenerates ascorbate; thiamine status governs folate import. Single-nutrient repletion frequently moves the bottleneck to the partner.
Drugs are the commonest cause of acquired deficiency. PPIs (B12, magnesium, iron, zinc, calcium), metformin (B12), combined oral contraceptives (B6, folate, B12, zinc, magnesium, with raised copper), statins (CoQ10, with a possible K2 effect), loop and thiazide diuretics (magnesium, potassium, thiamine, zinc), antibiotics (K2, B vitamins via the microbiome), methotrexate, sulfasalazine, and trimethoprim (folate), nitrous oxide (B12), valproate (carnitine, biotin), anticonvulsants (folate, vitamin D, biotin), cholestyramine and orlistat (fat-soluble vitamins), and alcohol (thiamine, folate, B6, magnesium, zinc, vitamin A).
Genotype sets the requirement. MTHFR C677T (riboflavin and folate), BCO1 (preformed vitamin A), FADS1/2 (EPA and DHA rather than ALA), HFE (iron restriction), TCN2 and FUT2 (B12 delivery and uptake), GC and VDR (vitamin D dose and interpretation), SLC19A1 and SLC19A2/3 (folate and thiamine transport), CBS and SUOX (sulfur handling), SLC22A5 (carnitine), PEMT (choline), and COMT and HNMT (methyl donor tolerance). These are the variants the gene reports on this site are built around.
Sequence and dose. Food sources first; one agent at a time; the lowest dose that moves the functional marker; recheck at 12 weeks. Iron, copper, selenium, iodine, potassium, vitamin A, and vitamin K each have a narrow or clinically important toxicity window and are dosed to laboratory values.
Educational and research content, not medical advice. The author holds a PhD in cellular and molecular nutrition, is not a licensed physician, and does not diagnose, treat, cure, or prevent disease. Functional ranges are research positions for discussion with a qualified clinician, who should manage any agent with a toxicity window or drug interaction.
